Synonyms: darapladib; Darapladib; N-(2-(Diethylamino)ethyl)-2-(2-((4-fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)-N-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)acetamide; Darapladib [USAN:INN]; SB480848; Darapladib (JAN/USAN); darapladib-sb-480848; Darapladib; SB-480848; MLS006010424; GTPL6696; SCHEMBL2742709; C36H38F4N4O2S; 356057-34-6; DTXSID70189073; HMS3653B13; AOB87381; BCP04908; EX-A2245; ZINC3842798; BDBM50125265; FD5008; MFCD18251452; s7520; SB-480848; AKOS025290042; BCP9000585; CS-1035; PB30298; KS-0000000O; NCGC00386337-05; 4CA-0439; AS-17025; BC600747; HY-10521; Darapladib (SB-480848); SC-94293; SMR004701449; AB0032591; SB-435445; FT-0725571; SW219569-1; X5943; A14274; D03650; Q-4415; UNII-UI1U1MYH09; A822896; 1H-Cyclopentapyrimidine-1-acetamide, N-(2-(diethylamino)ethyl)-2-(((4-fluorophenyl)methyl)thio)-4,5,6,7-tetrahydro-4-oxo-N-((4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)methyl)-; N-(2-(Diethylamino)ethyl)-2-(2-((4-fluorobenzyl)sulfanyl)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopentapyrimidin-1-yl)-N-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)acetamide; N-(2-Diethylamino-ethyl)-2-[2-(4-fluoro-benzylsulfanyl)-4-oxo-4,5,6,7-tetrahydro-cyclopentapyrimidin-1-yl]-N-(4''-trifluoromethyl-biphenyl-4-ylmethyl)-acetamide; N-(2-diethylaminoethyl)-2-[2-[(4-fluorophenyl)methylsulfanyl]-4-oxo-6,7-dihydro-5H-cyclopenta[e]pyrimidin-1-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide; N-[2-(diethylamino)ethyl]-2-[2-[(4-fluorophenyl)methylsulfanyl]-4-oxidanylidene-6,7-dihydro-5H-cyclopenta[d]pyrimidin-1-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]ethanamide; N-[2-(Diethylamino)ethyl]-2-[2-[(4-fluorophenyl)methylsulfanyl]-4-oxo-6,7-dihydro-5h-cyclopenta[d]pyrimidin-1-yl]-n-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide; N-[2-(diethylamino)ethyl]-2-[2-[(4-fluorophenyl)methylthio]-4-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-1-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide; N-[2-(DIETHYLAMINO)ETHYL]-N-[4'-(TRIFLUOROMETHYL)-1,1'-BIPHENYL-4-YLMETHYL]-2-[2-(4-FLUOROBENZYLTHIO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-CYCLOPENTA[D]PYRIMIDIN-1-YL]ACETAMIDE; N-[2-(Diethylamino)ethyl]-N-[4'-(trifluoromethyl)-4-biphenylylmethyl]-2-(4-fluorobenzylthio)-4-oxo-5,6-propano-1,4-dihydropyrimidine-1-acetamide; SB 480848; Darapladib (USAN); Darapladib [USAN]; D0L5UO; CID9939609; A3349; 1H-CYCLOPENTAPYRIMIDINE-1-ACETAMIDE, N-[2-(DIETHYLAMINO)ETHYL]-2-[[(4-FLUOROPHENYL)METHYL]THIO]-4,5,6,7-TETRAHYDRO-4-OXO-N-[[4'-(TRIFLUOROMETHYL)[1,1'-BIPHENYL]-4-YL]METHYL]-; N-[2-(Diethylamino)ethyl]-2-{2-[(4-Fluorobenzyl)sulfanyl]-4-Oxo-4,5,6,7-Tetrahydro-1h-Cyclopenta[d]pyrimidin-1-Yl}-N-{[4'-(Trifluoromethyl)biphenyl-4-Yl]methyl}acetamide; UI1U1MYH09; CHEMBL204021; AK172112;